Skip to main navigation Skip to search Skip to main content

Effectiveness and safety of amivantamab in EGFR exon 20 insertion (E20I) mutations in non-small cell lung cancer (NSCLC)

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Effectiveness and safety of amivantamab in EGFR exon 20 insertion (E20I) mutations in non-small cell lung cancer (NSCLC)'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry